Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
195
-
Total 13F shares, excl. options
-
66,510,322
-
Shares change
-
-2,098,745
-
Total reported value, excl. options
-
$2,843,816,628
-
Value change
-
-$67,049,318
-
Put/Call ratio
-
84%
-
Number of buys
-
101
-
Number of sells
-
-99
-
Price
-
$42.76
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q4 2015
235 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q4 2015.
IMPAX LABORATORIES INC - COM (IPXL) has 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66,510,322 shares
.
Largest 10 shareholders include Hound Partners, LLC (6,980,266 shares), ORBIMED ADVISORS LLC (6,664,100 shares), BlackRock Fund Advisors (5,484,063 shares), VANGUARD GROUP INC (5,176,732 shares), Invesco Ltd. (3,528,784 shares), ARAVT GLOBAL LLC (3,071,878 shares), FRANKLIN RESOURCES INC (2,473,698 shares), Pennant Capital Management, LLC (2,321,581 shares), STATE STREET CORP (1,847,596 shares), and UBS ASSET MANAGEMENT AMERICAS INC (1,828,215 shares).
This table shows the top 195 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.